Fass DM, Schroeder FA, Perlis RH, Haggarty SJ. Epigenetic mechanisms in mood disorders: targeting neuroplasticity. Neuroscience. 2014;264:112-30. doi:10.1016/j.neuroscience.2013.01.041
Grgic I, Hofmeister AF, Genovese G, et al. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int. 2014;86(6):1116-29. doi:10.1038/ki.2014.204
Haesemeyer M, Schier AF. The study of psychiatric disease genes and drugs in zebrafish. Curr Opin Neurobiol. 2015;30:122-30. doi:10.1016/j.conb.2014.12.002
Carroll JB, Deik A, Fossale E, et al. HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation. PLoS One. 2015;10(8):e0134465. doi:10.1371/journal.pone.0134465
Hatzios SK, Abel S, Martell J, et al. Chemoproteomic profiling of host and pathogen enzymes active in cholera. Nat Chem Biol. 2016;12(4):268-74. doi:10.1038/nchembio.2025
Chatterjee S, Kapoor A, Akiyama JA, et al. Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease. Cell. 2016;167(2):355-368.e10. doi:10.1016/j.cell.2016.09.005
Gräff J, Kahn M, Samiei A, et al. A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J Neurosci. 2013;33(21):8951-60. doi:10.1523/JNEUROSCI.5657-12.2013
Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014;40(6):843-54. doi:10.1016/j.immuni.2014.05.013
Shema R, Kulicke R, Cowley GS, Stein R, Root DE, Heiman M. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington’s disease. Proc Natl Acad Sci U S A. 2015;112(1):268-72. doi:10.1073/pnas.1417231112
Kaiser T, Feng G. Modeling psychiatric disorders for developing effective treatments. Nat Med. 2015;21(9):979-88. doi:10.1038/nm.3935